Skip to content

Study for correlation of health effects between vitamin K2 and glycolipid metabolism as well as gut microbiota of type II diabetes patients

Study for correlation of health effects between vitamin K2 and glycolipid metabolism as well as gut microbiota of type II diabetes patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019663
Enrollment
Unknown
Registered
1990-01-01
Start date
2019-05-15
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Case series:Fortified vitamin k2 yogurt
Control series:yogurt

Sponsors

Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 40-70 years old (the age is calculated according to the difference between the screening survey date and the date of birth), with type 2 diabetes confirmed by community hospital and with clear disease history 2. Patients with no serious diabetic complications, such as leg ulcers, severe liver and kidney damage, severe neurological diseases, severe retinopathy, etc.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Alcoholism (drinking more than 5 times a week, an average of 2 two white wines or half a catty of yellow wine or more than 5 bottles of beer); 3. Suffering from a serious mental illness in the past 6 months; 4. In the past 3 months, patients who received medical treatment for the following diseases: cholecystitis, peptic ulcer, urinary tract infection, acute pyelonephritis, cystitis, hyperthyroidism and other thyroid dysfunction; 5. Have undergone gastrointestinal surgery, except for appendicitis and hernia surgery; 6. Chronic, prolonged hepatitis patients, patients with severe liver disease such as cirrhosis or hepatitis B virus surface antigen (HBsAg) positive with abnormal liver function (serum alanine aminotransferase and aspartate aminotransferase is 2.5 times normal); 7. suffering from IBD, Cushing syndrome; 8. suffering from pituitary dysfunction; 9. Suffering from serious organic diseases such as cancer, coronary heart disease, myocardial infarction and stroke; 10. Have infectious diseases such as tuberculosis and AIDS; 11. Physical disability, or other causes of life can not take care of themselves, can not clearly recall, answer questions; 12. In the past 3 months, any medicine (including appetite inhibitors such as fluoropropionamide and thyroid hormones, progesterone, laxatives, etc. and various Chinese medicine ingredients diet pills) or surgical methods for weight loss; antibiotics used in the past 3 months; 13. There are obvious movement disorders; 14. There is no guarantee of sufficient time to participate in this project.

Design outcomes

Primary

MeasureTime frame
glycosylated hemoglobin;fasting glucose;serum dp-ucMGP;fasting insulin;gut microbiota;

Countries

China

Contacts

Public ContactLi Ying

Harbin Medical University

liying_helen@163.com+86 18245132681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026